“…Lymphosarcoma, gastrointestinal carcinomas, mesenteric mesenchymoma, and lymphoma have been associated with protein‐losing enteropathy 1,2,6. Proposed mechanisms for the occurrence of PLE in malignancy include protein loss through the inflamed or ulcerated mucosa, such as in gastrointestinal carcinomas, direct tumor infiltration such as lymphoma, lymphatic obstruction with heart failure, and chronically elevated right‐sided venous pressure from carcinoid syndrome, neurohumoral effects of substances secreted by tumor such as VIP or catecholamines, and lymphatic obstruction by tumor and development of secondary intestinal lymphangiectasia 1–4. Neurohumoral factors such as VIP can be responsible for the development of PLE in neuroblastoma.…”